Author

Daniel Bottomly

Oregon Health & Science UniversityORCID 0000-0001-7191-0990Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alexandria Miller· 1 shared Andy J. KaempfiD· 1 shared Christopher A. EideiD· 1 shared Curtis Lachowiez· 1 shared Jean C. Y. WangiD· 1 shared Jeffrey W TyneriD· 1 shared John Edgar DickiD· 1 shared Nicola LongiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexandria Miller

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 8, 2025

A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard Therapies

Stephen E. Kurtz, Christopher A. Eide, Andy J. Kaempf…·Jeffrey W Tyner

This paper develops a rapid qPCR-based gene expression profiler to predict AML patient response to standard therapies using cell state and BCL2 family gene expression signatures.

DOI 10.1101/2025.10.08.681215

humanbulk RNA-seq

𝕏 PostBluesky